Difference between revisions of "Part:BBa K5382160"
Chenyuyanyan (Talk | contribs) |
Chenyuyanyan (Talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
<partinfo>BBa_K5382160 short</partinfo> | <partinfo>BBa_K5382160 short</partinfo> | ||
| − | InaK is a kind of ice nucleoprotein of Pseudomonas syringae KCTC1832. Ice nucleoprotein is a kind of protein that can promote the formation of ice crystals in organisms. Its N-terminal domain can be tightly anchored to the surface of Escherichia coli cells as an anchor moda, so as to enable surface display.<br> | + | The InaK is a kind of ice nucleoprotein of <i>Pseudomonas syringae</i> KCTC1832. Ice nucleoprotein is a kind of protein that can promote the formation of ice crystals in organisms. Its N-terminal domain can be tightly anchored to the surface of Escherichia coli cells as an anchor moda, so as to enable surface display.<br> |
| − | + | The linker here is a short peptide used to connect the Inak and z domain.<br> | |
| − | z domain refers to a synthetic protein domain that has the ability to bind to the Fc region of immunoglobulin G (IgG). In our project, z domains are used to construct extracellular vesicles (EVs) that can display antibodies, so that these EVs can bind specific antibodies through the z domain on their surface, so as to achieve targeted delivery to specific cells or tissues [1]. | + | The z domain refers to a synthetic protein domain that has the ability to bind to the Fc region of immunoglobulin G (IgG). In our project, z domains are used to construct extracellular vesicles (EVs) that can display antibodies, so that these EVs can bind specific antibodies through the z domain on their surface, so as to achieve targeted delivery to specific cells or tissues <sup>[1]</sup>. |
The 4z domain, a tetramer of the z domain, has been shown in the literature to be equally capable of constructing EVs displaying antibodies, and has similar binding activity to the z domain. | The 4z domain, a tetramer of the z domain, has been shown in the literature to be equally capable of constructing EVs displaying antibodies, and has similar binding activity to the z domain. | ||
| + | ===References=== | ||
| + | [1] Oscar P B Wiklander;Doste R Mamand;Dara K Mohammad;Wenyi Zheng;Rim Jawad Wiklander;Taras Sych;Antje M Zickler;Xiuming Liang;Heena Sharma;Andrea Lavado;Jeremy Bost;Samantha Roudi;Giulia Corso;Angus J Lennaárd;Manuchehr Abedi Valugerdi;Imre Mäger;Evren Alici;Erdinc Sezgin;Joel Z Nordin;Dhanu Gupta;André Görgens;Samir El Andaloussi.Antibody-displaying extracellular vesicles for targeted cancer therapy.[J].Nature biomedical engineering,2024,() | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
Latest revision as of 12:34, 2 October 2024
InaK-linker-4z domain_protein domain that have the ability to bind to lgG
The InaK is a kind of ice nucleoprotein of Pseudomonas syringae KCTC1832. Ice nucleoprotein is a kind of protein that can promote the formation of ice crystals in organisms. Its N-terminal domain can be tightly anchored to the surface of Escherichia coli cells as an anchor moda, so as to enable surface display.
The linker here is a short peptide used to connect the Inak and z domain.
The z domain refers to a synthetic protein domain that has the ability to bind to the Fc region of immunoglobulin G (IgG). In our project, z domains are used to construct extracellular vesicles (EVs) that can display antibodies, so that these EVs can bind specific antibodies through the z domain on their surface, so as to achieve targeted delivery to specific cells or tissues [1].
The 4z domain, a tetramer of the z domain, has been shown in the literature to be equally capable of constructing EVs displaying antibodies, and has similar binding activity to the z domain.
References
[1] Oscar P B Wiklander;Doste R Mamand;Dara K Mohammad;Wenyi Zheng;Rim Jawad Wiklander;Taras Sych;Antje M Zickler;Xiuming Liang;Heena Sharma;Andrea Lavado;Jeremy Bost;Samantha Roudi;Giulia Corso;Angus J Lennaárd;Manuchehr Abedi Valugerdi;Imre Mäger;Evren Alici;Erdinc Sezgin;Joel Z Nordin;Dhanu Gupta;André Görgens;Samir El Andaloussi.Antibody-displaying extracellular vesicles for targeted cancer therapy.[J].Nature biomedical engineering,2024,() Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 2299
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 722
Illegal NgoMIV site found at 962
Illegal NgoMIV site found at 1130
Illegal AgeI site found at 517 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 692
Illegal BsaI.rc site found at 1182
Illegal SapI.rc site found at 326
Illegal SapI.rc site found at 1951